Cargando…

A novel heterozygous mutation c.680A>G (p. N227S) in SLC34A1 gene leading to autosomal dominant hypophosphatemia: A case report

RATIONALE: Currently, the relationship between heterozygous mutations in SLC34A1 and hypophosphatemia is controversial. Here we report an autosomal dominant hypophosphatemia pedigree carrying a novel heterozygous mutation in SLC34A1. PATIENT CONCERNS: The proband is a 32-year old young man, presente...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiang, Xie, Ying, Wan, Shan, Xu, Jin, Cai, Bei, Zhang, Yi, Yu, Xijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531229/
https://www.ncbi.nlm.nih.gov/pubmed/31096470
http://dx.doi.org/10.1097/MD.0000000000015617
_version_ 1783420790703652864
author Chen, Xiang
Xie, Ying
Wan, Shan
Xu, Jin
Cai, Bei
Zhang, Yi
Yu, Xijie
author_facet Chen, Xiang
Xie, Ying
Wan, Shan
Xu, Jin
Cai, Bei
Zhang, Yi
Yu, Xijie
author_sort Chen, Xiang
collection PubMed
description RATIONALE: Currently, the relationship between heterozygous mutations in SLC34A1 and hypophosphatemia is controversial. Here we report an autosomal dominant hypophosphatemia pedigree carrying a novel heterozygous mutation in SLC34A1. PATIENT CONCERNS: The proband is a 32-year old young man, presented with progressive pain and weakness in his lower extremities for more than 5 years. The proband showed persistent hypophosphatemia and low TmPO4/GFR values, indicating renal phosphate leak. His grandfather, father, and one of his uncles showed the similar symptoms. DIAGNOSES: Autosomal dominant hypophosphatemia. INTERVENTIONS AND OUTCOMES: Phosphorus supplement was prescribed to the proband and his affected uncle. Both their serum phosphorus levels recovered to normal and their symptoms such as back pain and lower extremity weakness were completely relieved. Whole exome sequencing was performed to identify disease-causing mutations in proband. LESSONS: A novel heterozygous missense mutation c.680A>G (p. N227S) in exon 7 of SLC34A1 was found in proband by whole exome sequencing, which was also found in other 4 family members of this pedigree. Our report of an autosomal dominant hypophosphatemia pedigree with 5 mutant carriers enriches the clinical phenotype caused by the SLC34A1 mutations and further affirms the heterozygous mutations are causative for hypophosphatemia.
format Online
Article
Text
id pubmed-6531229
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-65312292019-06-25 A novel heterozygous mutation c.680A>G (p. N227S) in SLC34A1 gene leading to autosomal dominant hypophosphatemia: A case report Chen, Xiang Xie, Ying Wan, Shan Xu, Jin Cai, Bei Zhang, Yi Yu, Xijie Medicine (Baltimore) Research Article RATIONALE: Currently, the relationship between heterozygous mutations in SLC34A1 and hypophosphatemia is controversial. Here we report an autosomal dominant hypophosphatemia pedigree carrying a novel heterozygous mutation in SLC34A1. PATIENT CONCERNS: The proband is a 32-year old young man, presented with progressive pain and weakness in his lower extremities for more than 5 years. The proband showed persistent hypophosphatemia and low TmPO4/GFR values, indicating renal phosphate leak. His grandfather, father, and one of his uncles showed the similar symptoms. DIAGNOSES: Autosomal dominant hypophosphatemia. INTERVENTIONS AND OUTCOMES: Phosphorus supplement was prescribed to the proband and his affected uncle. Both their serum phosphorus levels recovered to normal and their symptoms such as back pain and lower extremity weakness were completely relieved. Whole exome sequencing was performed to identify disease-causing mutations in proband. LESSONS: A novel heterozygous missense mutation c.680A>G (p. N227S) in exon 7 of SLC34A1 was found in proband by whole exome sequencing, which was also found in other 4 family members of this pedigree. Our report of an autosomal dominant hypophosphatemia pedigree with 5 mutant carriers enriches the clinical phenotype caused by the SLC34A1 mutations and further affirms the heterozygous mutations are causative for hypophosphatemia. Wolters Kluwer Health 2019-05-17 /pmc/articles/PMC6531229/ /pubmed/31096470 http://dx.doi.org/10.1097/MD.0000000000015617 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle Research Article
Chen, Xiang
Xie, Ying
Wan, Shan
Xu, Jin
Cai, Bei
Zhang, Yi
Yu, Xijie
A novel heterozygous mutation c.680A>G (p. N227S) in SLC34A1 gene leading to autosomal dominant hypophosphatemia: A case report
title A novel heterozygous mutation c.680A>G (p. N227S) in SLC34A1 gene leading to autosomal dominant hypophosphatemia: A case report
title_full A novel heterozygous mutation c.680A>G (p. N227S) in SLC34A1 gene leading to autosomal dominant hypophosphatemia: A case report
title_fullStr A novel heterozygous mutation c.680A>G (p. N227S) in SLC34A1 gene leading to autosomal dominant hypophosphatemia: A case report
title_full_unstemmed A novel heterozygous mutation c.680A>G (p. N227S) in SLC34A1 gene leading to autosomal dominant hypophosphatemia: A case report
title_short A novel heterozygous mutation c.680A>G (p. N227S) in SLC34A1 gene leading to autosomal dominant hypophosphatemia: A case report
title_sort novel heterozygous mutation c.680a>g (p. n227s) in slc34a1 gene leading to autosomal dominant hypophosphatemia: a case report
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531229/
https://www.ncbi.nlm.nih.gov/pubmed/31096470
http://dx.doi.org/10.1097/MD.0000000000015617
work_keys_str_mv AT chenxiang anovelheterozygousmutationc680agpn227sinslc34a1geneleadingtoautosomaldominanthypophosphatemiaacasereport
AT xieying anovelheterozygousmutationc680agpn227sinslc34a1geneleadingtoautosomaldominanthypophosphatemiaacasereport
AT wanshan anovelheterozygousmutationc680agpn227sinslc34a1geneleadingtoautosomaldominanthypophosphatemiaacasereport
AT xujin anovelheterozygousmutationc680agpn227sinslc34a1geneleadingtoautosomaldominanthypophosphatemiaacasereport
AT caibei anovelheterozygousmutationc680agpn227sinslc34a1geneleadingtoautosomaldominanthypophosphatemiaacasereport
AT zhangyi anovelheterozygousmutationc680agpn227sinslc34a1geneleadingtoautosomaldominanthypophosphatemiaacasereport
AT yuxijie anovelheterozygousmutationc680agpn227sinslc34a1geneleadingtoautosomaldominanthypophosphatemiaacasereport
AT chenxiang novelheterozygousmutationc680agpn227sinslc34a1geneleadingtoautosomaldominanthypophosphatemiaacasereport
AT xieying novelheterozygousmutationc680agpn227sinslc34a1geneleadingtoautosomaldominanthypophosphatemiaacasereport
AT wanshan novelheterozygousmutationc680agpn227sinslc34a1geneleadingtoautosomaldominanthypophosphatemiaacasereport
AT xujin novelheterozygousmutationc680agpn227sinslc34a1geneleadingtoautosomaldominanthypophosphatemiaacasereport
AT caibei novelheterozygousmutationc680agpn227sinslc34a1geneleadingtoautosomaldominanthypophosphatemiaacasereport
AT zhangyi novelheterozygousmutationc680agpn227sinslc34a1geneleadingtoautosomaldominanthypophosphatemiaacasereport
AT yuxijie novelheterozygousmutationc680agpn227sinslc34a1geneleadingtoautosomaldominanthypophosphatemiaacasereport